USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: BIOUSIAN BIOSYSTEMS, INC. (BBI)
City: LEXINGTON
State: MA
Zip+4: 02421
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $199,556.00 1
SBIR Phase II $992,331.00 1

Award List:

Novel Glycosylated Delta Opioid Receptor Agonists for Chronic Inflammatory Pain

Award Year / Program / Phase: 2009 / SBIR / Phase I
Agency: HHS
Principal Investigator: Kimberley S. Gannon
Award Amount: $199,556.00
Abstract:
DESCRIPTION (provided by applicant): Biousian Biosystems Inc. (BBI) intends to develop novel, glycosylated, deltorphin-based peptides as orally available drugs for the treatment of chronic inflammatory pain. By targeting a 4-selective mechanism, it is anti cipated that compounds with improved… More

Novel Glycosylated Delta Opioid Receptor Agonists for Chronic Inflammatory Pain

Award Year / Program / Phase: 2011 / SBIR / Phase II
Agency: HHS
Principal Investigator: Mark S. Kleven – 215-910-2261
Award Amount: $992,331.00
Abstract:
DESCRIPTION (provided by applicant): Traditionally, Mu opioid receptor (MOR) agonists have not been given as first line treatments for neuropathic pain due to their significant adverse side effects. Biousian Biosystems Inc, (BBI) is developing novel glycosylated peptide-based delta opioid receptor… More